ITRM Volume dana dhuwit perusahaan Iterum Therapeutics plc

Logo grafis Iterum Therapeutics plc (ITRM)

Iterum Therapeutics plc relies on research centers in the US and Ireland to develop antibiotics targeting resistant infections. The level of cash resources confirms current liquidity status, where the 0.00 mark serves as a key metric. Drug production is fully outsourced to external CMO partners. Meanwhile, the expansion of sales markets for oral medications treating urinary tract infections ensures stable global demand.

Iterum Therapeutics plc - Gunggung dana dhuwit perusahaan ITRM (periode 04.07.2022 - 11.04.2026)

Rincian metrik keuangan lan pasar Iterum Therapeutics (ITRM)

- nilai saham lan prakiraan konsensus rega:
Analisis komprehensif perusahaan:ITRM Iterum Therapeutics plc
Produk mawa merek iterumtx.com

This indicator tracks the volume of highly liquid assets, determining the company's ability to cover operating expenses without incurring external debt. An analysis of the current cash position on GURU.Markets allows for an assessment of the financial stability of Iterum Therapeutics plc (ITRM), which is critical for maintaining complex international antibiotic logistics and minimizing risks when supplying hospitals under regulatory constraints.